From Molecular Insights to Cancer Treatments: Progress in Translational Science
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 30 April 2026 | Viewed by 39
Special Issue Editors
Interests: chemical biology; medicinal chemistry; translational cancer biology
Interests: radiation biology; cancer biology; translational cancer biology
Special Issue Information
Dear Colleagues,
Advances in cancer biology continue to drive the discovery of novel therapeutic strategies, yet significant challenges remain in translating these insights into effective treatments. This Special Issue explores the intersection of cancer biology, early discovery, and translational research, highlighting innovative approaches in translational sciences. We welcome original research and review articles covering key aspects of basic scientific discoveries, from identifying new molecular targets to preclinical- and early-clinical-stage investigations. Topics of interest include mechanisms of cancer progression, novel drug candidates, resistance pathways, and strategies to improve therapeutic efficacy. By synthesizing cutting-edge research, this issue aims to foster interdisciplinary dialogue and accelerate the development of next-generation cancer therapies.
Prof. Dr. Sanjay V. Malhotra
Dr. Dhanir Tailor
Dr. Annah Rolig
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer biology
- therapeutics
- molecular targets
- translational research
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
